KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Edwards Lifesciences (EW) Operating Expenses (2016 - 2025)

Edwards Lifesciences (EW) has 17 years of Operating Expenses data on record, last reported at $1.1 billion in Q4 2025.

  • For Q4 2025, Operating Expenses rose 39.14% year-over-year to $1.1 billion; the TTM value through Dec 2025 reached $3.5 billion, up 20.11%, while the annual FY2025 figure was $3.5 billion, 21.06% up from the prior year.
  • Operating Expenses reached $1.1 billion in Q4 2025 per EW's latest filing, up from $885.7 million in the prior quarter.
  • Across five years, Operating Expenses topped out at $1.1 billion in Q4 2025 and bottomed at $7.1 million in Q4 2021.
  • Average Operating Expenses over 5 years is $635.8 million, with a median of $675.5 million recorded in 2022.
  • Peak YoY movement for Operating Expenses: plummeted 98.45% in 2021, then skyrocketed 5273.24% in 2022.
  • A 5-year view of Operating Expenses shows it stood at $7.1 million in 2021, then surged by 5273.24% to $381.5 million in 2022, then skyrocketed by 54.02% to $587.6 million in 2023, then surged by 31.99% to $775.6 million in 2024, then surged by 39.14% to $1.1 billion in 2025.
  • Per Business Quant database, its latest 3 readings for Operating Expenses were $1.1 billion in Q4 2025, $885.7 million in Q3 2025, and $793.7 million in Q2 2025.